Clinical Trials Browser

Phase 2 × Leukemia, Myelomonocytic, Chronic × Hydroxyurea × Clear all

Leukemia, Myelomonocytic, Chronic

NCT00083187 2013-07-18

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia

Congenital Abnormalities, Leukemia, Myelodysplastic Syndromes, Myeloproliferative Disorders, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative

Clinical Trials

PROSPERA

VNP40101M in Treating Patients With Acute Myelogenous Leukemia or High-Risk Myelodysplasia